References: Monitoring aminoglycoside plasma concentrations

  • Llanos-Paez CC, Staatz CE, Lawson R, Hennig S. A population pharmacokinetic model of gentamicin in pediatric oncology patients to facilitate personalized dosing. Antimicrob Agents Chemother 2017;61(8). https://www.ncbi.nlm.nih.gov/pubmed/28533244
  • Yamada T, Fujii S, Shigemi A, Takesue Y. A meta-analysis of the target trough concentration of gentamicin and amikacin for reducing the risk of nephrotoxicity. J Infect Chemother 2021;27(2):256-61. https://www.ncbi.nlm.nih.gov/pubmed/33077364